- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ICYMI: Top Highlights From ACC 2022
The American College of Cardiology’s 71st Scientific Session covered how to address the impact of social determinants of health on cardiovascular outcomes, understanding the latest developments in digital health, and the role of COVID-19 on heart health.
The American College of Cardiology’s 71st Scientific Session was held on April 2-4, 2022, in Washington, DC, with a program that covered how to address the impact of social determinants of health on cardiovascular outcomes, understanding the latest developments in digital health, and the role of COVID-19 on heart health.
Here are the key takeaways from the meeting.
New HF Definition, Stage Updates Outlined in 2022 ACC/AHA/HFSA Guidelines
A panel of experts highlighted updates to the 2022 American Heart Association (AHA)/ACC/Heart Failure Society of America (HFSA) guidelines. New additions included better management that incorporated social determinants of health and a new definition for heart failure.
Dr Raul Santos Explains the Benefits of Treating Children With FH Early
Raul Santos, MD, PhD, director, Lipid Clinic at the Heart Institute, and associate professor, University of São Paulo Medical School, Brazil, spoke on the benefits and risks of early treatment for children with familial hypercholesterolemia (FH).
SCORED: Sotagliflozin Leads to Reductions in CV Death, MI, Stroke Regardless of CVD Presence
Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular (CV) programs at Brigham and Women’s Hospital Heart & Vascular Center and professor of medicine at Harvard Medical School, presented updated findings from the SCORED trial that further highlight the benefits of sotagliflozin among patients with type 2 diabetes and chronic kidney disease.
Consider the Whole Patient When Choosing Treatment, Says Dr Marc Bonaca
“We have to treat our patients, not disease states,” said Marc Bonaca, MD, MPH, CPC of Clinical Research, CPC of Community Health, University of Colorado School of Medicine, in an interview on holistic approaches and rivaroxaban treatment.
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
